Found: 6
Select item for more details and to access through your institution.
LALF-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.
- Published in:
- Clinical & Experimental Metastasis, 2017, v. 34, n. 3/4, p. 241, doi. 10.1007/s10585-017-9846-x
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183177
- By:
- Publication type:
- Article
Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF<sub>32-51</sub> region.
- Published in:
- Journal of Peptide Science, 2010, v. 16, n. 1, p. 40, doi. 10.1002/psc.1192
- By:
- Publication type:
- Article
Influence of Cell Disruption Methods on the Recovery and Immunogenicity of a Fusion Protein for a Therapeutic Cancer Vaccine Against HPV.
- Published in:
- BioProcessing Journal, 2015, v. 14, n. 4, p. 22
- By:
- Publication type:
- Article
LALF<sub>32‐51</sub>‐E7, a HPV‐16 therapeutic vaccine candidate, forms protein body‐like structures when expressed in <italic>Nicotiana benthamiana</italic> leaves.
- Published in:
- Plant Biotechnology Journal, 2018, v. 16, n. 2, p. 628, doi. 10.1111/pbi.12802
- By:
- Publication type:
- Article